Marine-derived bioactive compounds with anti-obesity effect: A review

Journal of Functional Foods

Volumn 21, Issue , 2016, Pages 372-387

  Hu, Xiaoqian ^a   Tao, Ningping ^a   Wang, Xichang ^a   Xiao, Jianbo ^b   Wang, Mingfu ^a  

^a SHANGHAI OCEAN UNIVERSITY   (China)

^b University of Macau   (Macao)

Author keywords

Adipogenesis; Appetite; Fat absorption; Functional compounds; Marine food; Thermogenesis

Indexed keywords

EID: 84957964449     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.12.006     Document Type: Review

References (130)

1. Ahmadian M., Duncan R.E., Jaworski K., Sarkadi-Nagy E., Sul H.S. Triacylglycerol metabolism in adipose tissue. Future Lipidology 2007, 2:229-237.
2. Ali A.T., Hochfeld W.E., Myburgh R., Pepper M.S. Adipocyte and adipogenesis. European Journal of Cell Biology 2013, 92:229-236.
3. Arunkumar E., Bhuvaneswari S., Anuradha C.V. An intervention study in obese mice with astaxanthin, a marinecarotenoid - Effects on insulin signaling and pro-inflammatory cytokines. Food & Function 2012, 3:120-126.
4. Baillie R., Takada R., Nakamura M., Clarke S. Coordinate induction of peroxisomal acyl-CoA oxidase and UCP-by dietary fish oil: A mechanism for decreased body fat deposition. Prostaglandins, Leukotrienes, and Essential Fatty Acids 1999, 60:351-356.
5. Ben Henda Y., Laamari M., Lanneluc I., Travers M.-A., Agogué H., Arnaudin I., Bridiau N., Maugard T., Piot J.-M., Sannier F., Bordenave-Juchereau S. Di and tripeptides from marine sources can target adipogenic process and contribute to decrease adipocyte number and functions. Journal of Functional Foods 2015, 17:1-10.
6. Birari R.B., Bhutani K.K. Pancreatic lipase inhibitors from natural sources: Unexplored potential. Drug Discovery Today 2007, 12:879-889.
7. Blunt J.W., Copp B.R., Keyzers R.A., Munro M., Prinsep M.R. Marine natural products. Natural Product Reports 2015, 32:116-211.
8. Bondiolotti G., Bareggi S.R., Frega N.G., Strabioli S., Cornelli U. Activity of two different polyglucosamines, L112® and FF45®, on body weight in male rats. European Journal of Pharmacology 2007, 567:155-158.
9. Bougatef A., Ravallec R., Nedjar-Arroume N., Barkia A., Guillochon D., Nasri M. Evidence of in vivo satietogen effect and control of food intake of smooth hound (Mustelus mustelus) muscle protein hydrolysate in rats. Journal of Functional Foods 2010, 2:10-16.
10. Brey C.W., Nelder M.P., Hailemariam T., Gaugler R., Hashmi S. Krüppel-like family of transcription factors: An emerging new frontier in fat biology. International Journal of Biological Sciences 2009, 5:622.
11. Brunetti L., Di Nisio C., Orlando G., Ferrante C., Vacca M. The regulation of feeding: A cross talk between peripheral and central signalling. International Journal of Immunopathology and Pharmacology 2005, 18:201-212.
12. Buckley J.D., Howe P.R. Long-chain omega-polyunsaturated fatty acids may be beneficial for reducing obesity-review. Nutrients 2010, 2:1212-1230.
13. Byun M.R., Lee C.H., Hwang J.-H., Kim A.R., Moon S.A., Sung M.K., Roh J.-R., Hwang E.S., Hong J.-H. Phorbaketal A inhibits adipogenic differentiation through the suppression of PPARγ-mediated gene transcription by TAZ. European Journal of Pharmacology 2013, 718:181-187.
14. Charlton M. Obesity, hyperlipidemia, and metabolic syndrome. Liver Transplantation 2009, 15:S83-S89.
15. Chatzigeorgiou A., Kandaraki E., Papavassiliou A.G., Koutsilieris M. Peripheral targets in obesity treatment: A comprehensive update. Obesity Reviews 2014, 15:487-503.
16. Combs A.P. Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer. Journal of Medicinal Chemistry 2009, 53:2333-2344.
17. Couet C., Delarue J., Ritz P., Antoine J., Lamisse F. Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. International Journal of Obesity 1997, 21:637-643.
18. de Celis Alonso B., Rayment P., Ciampi E., Ablett S., Marciani L., Spiller R.C., Norton I.T., Gowland P.A. NMR relaxometry and rheology of ionic and acid alginate gels. Carbohydrate Polymers 2010, 82:663-669.
19. Daniels J. Obesity: America's epidemic: What goes up does not always come down. Is there a solution?. The American Journal of Nursing 2006, 106:40-49.
20. Duca F.A., Lam T.K. Gut microbiota, nutrient sensing and energy balance. Diabetes, Obesity and Metabolism 2014, 16(Suppl. 1):68-76.
21. Duncan R.E., Ahmadian M., Jaworski K., Sarkadi-Nagy E., Sul H.S. Regulation of lipolysis in adipocytes. Annual Review of Nutrition 2007, 27:79-101.
22. Elangbam C. Review paper: Current strategies in the development of anti-obesity drugs and their safety concerns. Veterinary Pathology Online 2009, 46:10-24.
23. Eom S.H., Lee M.S., Lee E.W., Kim Y.M., Kim T.H. Pancreatic lipase inhibitory activity of phlorotannins isolated from Eisenia bicyclis. Phytotherapy Research 2013, 27:148-151.
24. Fabricatore A.N., Wadden T.A. Treatment of obesity: An overview. Clinical Diabetes 2003, 21:67.
25. Gades M.D., Stern J.S. Chitosan supplementation and fecal fat excretion in men. Obesity Research 2003, 11:683-688.
26. Gearhardt A.N., Bragg M.A., Pearl R.L., Schvey N.A., Roberto C.A., Brownell K.D. Obesity and public policy. Annual Review of Clinical Psychology 2012, 8:405-430.
27. Georg M.G., Kristensen M., Belza A., Knudsen J.C., Astrup A. Acute effect of alginate-based preload on satiety feelings, energy intake, and gastric emptying rate in healthy subjects. Obesity (Silver Spring) 2012, 20:1851-1858.
28. Görtzen A., Veh R.W. Obesity - An introduction to molecular mechanisms. Deutsches Aerzteblatt International 2007, 104:1166-1171.
29. Grönke S., Müller G., Hirsch J., Fellert S., Andreou A., Haase T., Jäckle H., Kühnlein R.P. Dual lipolytic control of body fat storage and mobilization in Drosophila. PLoS Biology 2007, 5:e137.
30. Guilak F., Lott K.E., Awad H.A., Cao Q., Hicok K.C., Fermor B., Gimble J.M. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. Journal of Cellular Physiology 2006, 206:229-237.
31. Han L., Kimura Y., Okuda H. Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet. International Journal of Obesity 1999, 23:174-179.
32. Harada K., Shen W.-J., Patel S., Natu V., Wang J., Osuga J.-I., Ishibashi S., Kraemer F.B. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice. American Journal of Physiology. Endocrinology and Metabolism 2003, 285:E1182-E1195.
33. Heck A.M., Yanovski J.A., Calis K.A. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2000, 20:270-279.
34. Heffernan N., Brunton N.P., FitzGerald R.J., Smyth T.J. Profiling of the molecular weight and structural isomer abundance of macroalgae-derived phlorotannins. Marine Drugs 2015, 13:509-528.
35. Hill J.O., Wyatt H.R., Peters J.C. Energy balance and obesity. Circulation 2012, 126:126-132.
36. Hoad C.L., Rayment P., Spiller R.C., Marciani L., de Celis Alonso B., Traynor C., Mela D.J., Peters H.P., Gowland P.A. In vivo imaging of intragastric gelation and its effect on satiety in humans. Journal of Nutrition 2004, 134:2293-2300.
37. Holm C. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochemical Society Transactions 2003, 31:1120-1124.
38. Holm C., Østerlund T., Laurell H., Contreras J.A. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annual Review of Nutrition 2000, 20:365-393.
39. Hoper A.C., Salma W., Khalid A.M., Hafstad A.D., Sollie S.J., Raa J., Larsen T.S., Aasum E. Oil from the marine zooplankton Calanus finmarchicus improves the cardiometabolic phenotype of diet-induced obese mice. British Journal of Nutrition 2013, 110:2186-2193.
40. Hoper A.C., Salma W., Sollie S.J., Hafstad A.D., Lund J., Khalid A.M., Raa J., Aasum E., Larsen T.S. Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice. Journal of Nutrition 2014, 144:164-169.
41. Hu X.-Q., Xu J., Xue Y., Li Z.-J., Wang J.-F., Wang J.-H., Xue C.-H., Wang Y.-M. Effects of bioactive components of sea cucumber on the serum, liver lipid profile and lipid absorption. Bioscience, Biotechnology, and Biochemistry 2012, 76:2214-2218.
42. Hubert H.B., Feinleib M., McNamara P.M., Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983, 67:968-977.
43. Hursting S.D., Nunez N.P., Varticovski L., Vinson C. The obesity-cancer link: Lessons learned from a fatless mouse. Cancer Research 2007, 67:2391-2393.
44. Idris I., Donnelly R. Sodium-glucose co-transporter-inhibitors: An emerging new class of oral antidiabetic drug. Diabetes, Obesity and Metabolism 2009, 11:79-88.
45. Inuzuka T., Yamamoto K., Iwasaki A., Ohno O., Suenaga K., Kawazoe Y., Uemura D. An inhibitor of the adipogenic differentiation of 3T3-L1 cells, yoshinone A, and its analogs, isolated from the marine cyanobacterium Leptolyngbya sp. Tetrahedron Letters 2014, 55:6711-6714.
46. Jensen M.G., Kristensen M., Astrup A. Effect of alginate supplementation on weight loss in obese subjects completing a 12-wk energy-restricted diet: A randomized controlled trial. The American Journal of Clinical Nutrition 2012, 96:5-13.
47. Jimeno J., Faircloth G., Sousa-Faro J., Scheuer P., Rinehart K. New marine derived anticancer therapeutics-journey from the sea to clinical trials. Marine Drugs 2004, 2:14-29.
48. Jo J., Gavrilova O., Pack S., Jou W., Mullen S., Sumner A.E., Cushman S.W., Periwal V. Hypertrophy and/or hyperplasia: Dynamics of adipose tissue growth. PLoS Computer Biology 2009, 5:e1000324.
49. Jung H.A., Islam M.N., Lee C.M., Jeong H.O., Chung H.Y., Woo H.C., Choi J.S. Promising antidiabetic potential of fucoxanthin isolated from the edible brown algae Eisenia bicyclis and Undaria pinnatifida. Fisheries Science 2012, 78:1321-1329.
50. Jung H.A., Jung H.J., Jeong H.Y., Kwon H.J., Ali M.Y., Choi J.S. Phlorotannins isolated from the edible brown alga Ecklonia stolonifera exert anti-adipogenic activity on 3T3-L1 adipocytes by downregulating C/EBPα and PPARγ. Fitoterapia 2014, 92:260-269.
51. Jung H.A., Jung H.J., Jeong H.Y., Kwon H.J., Kim M.-S., Choi J.S. Anti-adipogenic activity of the edible brown alga Ecklonia stolonifera and its constituent fucosterol in 3T3-L1 adipocytes. Archives of Pharmacal Research 2014, 37:713-720.
52. Kaats G.R., Michalek J.E., Preuss H.G. Evaluating efficacy of a chitosan product using a double-blinded, placebo-controlled protocol. Journal of the American College Nutrition 2006, 25:389-394.
53. Kanwal A., Banerjee S.K. SGLT inhibitors: A novel target for diabetes. Pharmaceutical Patent Analyst 2013, 2:77-91.
54. Kawada T., Kayahashi S., Hida Y., Koga K.-J., Nadachi Y., Fushiki T. Fish (bonito) oil supplementation enhances the expression of uncoupling protein in brown adipose tissue of rat. Journal of Agricultural and Food Chemistry 1998, 46:1225-1227.
55. Kim H.-K., Della-Fera M., Lin J., Baile C.A. Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. Journal of Nutrition 2006, 136:2965-2969.
56. Kim K.B.W.R., Jung J.Y., Cho J.Y., Ahn D.H. Lipase inhibitory activity of ethyl acetate fraction from Ecklonia cava extracts. Biotechnology and Bioprocess Engineering 2012, 17:739-745.
57. Kim K.-J., Lee O.-H., Lee B.-Y. Fucoidan, a sulfated polysaccharide, inhibits adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes. Life Science 2010, 86:791-797.
58. Kim M.-J., Chang U.-J., Lee J.-S. Inhibitory effects of fucoidan in 3T3-L1 adipocyte differentiation. Marine Biotechnology 2009, 11:557-562.
59. Kim S.-K., Kong C.-S. Anti-adipogenic effect of dioxinodehydroeckol via AMPK activation in 3T3-L1 adipocytes. Chemico-Biological Interactions 2010, 186:24-29.
60. Kimura M., Iida M., Yamauchi H., Suzuki M., Shibasaki T., Saito Y., Saito H. Astaxanthin supplementation effects on adipocyte size and lipid profile in OLETF rats with hyperphagia and visceral fat accumulation. Journal of Functional Foods 2014, 11:114-120.
61. Ko S.-C., Lee M., Lee J.-H., Lee S.-H., Lim Y., Jeon Y.-J. Dieckol, a phlorotannin isolated from a brown seaweed, Ecklonia cava, inhibits adipogenesis through AMP-activated protein kinase (AMPK) activation in 3T3-L1 preadipocytes. Environmental Toxicology and Pharmacology 2013, 36:1253-1260.
62. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
63. Kras K.M., Hausman D.B., Hausman G.J., Martin R.J. Adipocyte development is dependent upon stem cell recruitment and proliferation of preadipocytes. Obesity Research 1999, 7:491.
64. Kumar M.N.R. A review of chitin and chitosan applications. Reactive and Functional Polymers 2000, 46:1-27.
65. Lau J., Herzog H. CART in the regulation of appetite and energy homeostasis. Frontiers in Neuroscience 2014, 8:313.
66. Lavie C.J., McAuley P.A., Church T.S., Milani R.V., Blair S.N. Obesity and cardiovascular diseases. Journal of the American College of Cardiology 2014, 14:1345-1354.
67. Lawton C.L., Delargy H.J., Brockman J., Smith F.C., Blundell J.E. The degree of saturation of fatty acids influences post-ingestive satiety. British Journal of Nutrition 2000, 83:473-482.
68. Lee M.-S., Kwun I.-S., Kim Y. Eicosapentaenoic acid increases lipolysis through up-regulation of the lipolytic gene expression and down-regulation of the adipogenic gene expression in 3T3-L1 adipocytes. Genes & Nutrition 2008, 2:327-330.
69. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
70. Li B., Lu F., Wei X., Zhao R. Fucoidan: Structure and bioactivity. Molecules 2008, 13:1671-1695.
71. Li Y.-X., Wijesekara I., Li Y., Kim S.-K. Phlorotannins as bioactive agents from brown algae. Process Biochemistry 2011, 46:2219-2224.
72. Li Z.-S., Noda K., Fujita E., Manabe Y., Hirata T., Sugawara T. The green algal carotenoid siphonaxanthin inhibits adipogenesis in 3T3-L1 preadipocytes and the accumulation of lipids in white adipose tissue of KK-Ay mice. Journal of Nutrition 2015, 145:490-498.
73. Liu X., Cui J., Li Z., Xu J., Wang J., Xue C., Wang Y. Comparative study of DHA-enriched phospholipids and EPA-enriched phospholipids on metabolic disorders in diet-induced-obese C57BL/6J mice. European Journal of Lipid Science and Technology 2014, 116:255-265.
74. Liu X., Xue Y., Liu C., Lou Q., Wang J., Yanagita T., Xue C., Wang Y. Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice. Lipids in Health and Disease 2013, 12:109.
75. Lo K.A., Sun L. Turning WAT into BAT: A review on regulators controlling the browning of white adipocytes. Bioscience Reports 2013, 33.
76. Lunagariya N.A., Patel N.K., Jagtap S.C., Bhutani K.K. Inhibitors of pancreatic lipase: State of the art and clinical perspectives. Excli Journal 2014, 13:897-921.
77. Madsen L., Petersen R.K., Kristiansen K. Regulation of adipocyte differentiation and function by polyunsaturated fatty acids. Biochimica et Biophysica Acta 2005, 1740:266-286.
78. Maeda H., Hosokawa M., Sashima T., Funayama K., Miyashita K. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochemical and Biophysical Research Communications 2005, 332:392-397.
79. Maeda H., Hosokawa M., Sashima T., Takahashi N., Kawada T., Miyashita K. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. International Journal of Molecular Medicine 2006, 18:147-152.
80. Matsumoto M., Hosokawa M., Matsukawa N., Hagio M., Shinoki A., Nishimukai M., Miyashita K., Yajima T., Hara H. Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats. European Journal of Nutrition 2010, 49:243-249.
81. Melnikova I., Wages D. Anti-obesity therapies. Nature Reviews Drug Discovery 2006, 5:369-370.
82. Meyer C.W., Willershäuser M., Jastroch M., Rourke B.C., Fromme T., Oelkrug R., Heldmaier G., Klingenspor M. Adaptive thermogenesis and thermal conductance in wild-type and UCP1-KO mice. American Journal of Physiology 2010, 299:R1396-R1406.
83. Micallef M., Munro I., Phang M., Garg M. Plasma n-polyunsaturated fatty acids are negatively associated with obesity. British Journal of Nutrition 2009, 102:1370-1374.
84. Miyashita K., Nishikawa S., Beppu F., Tsukui T., Abe M., Hosokawa M. The allenic carotenoid fucoxanthin, a novel marine nutraceutical from brown seaweeds. Journal of Science Food Agriculture 2011, 91:1166-1174.
85. Moon H.E., Islam M.N., Ahn B.R., Chowdhury S.S., Sohn H.S., Jung H.A., Choi J.S. Protein tyrosine phosphatase 1B and α-glucosidase inhibitory phlorotannins from edible brown algae, Ecklonia stolonifera and Eisenia bicyclis. Bioscience, Biotechnology, and Biochemistry 2011, 75:1472-1480.
86. Nakajima S. Role of marine foods in prevention of obesity. Handbook of Seafood Quality, Safety and Health Applications 2010, 402-413. Wiley Online Library.
87. Nakatani T., Kim H.-J., Kaburagi Y., Yasuda K., Ezaki O. A low fish oil inhibits SREBP-proteolytic cascade, while a high-fish-oil feeding decreases SREBP-mRNA in mice liver relationship to anti-obesity. Journal of Lipid Research 2003, 44:369-379.
88. Nauck M., del Prato S., Meier J.J., Duran-Garcia S., Rohwedder K., Elze M., Parikh S.J. Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin. Deutsche Medizinische Wochenschrift 2011, 34:2015-2022.
89. Ogden C.L., Carroll M., Kit B.K., Flegal K.M. Prevalence of childhood and adult obesity in the United States, 2011-2012. Journal of the American Medical Association 2014, 311:806-814.
90. Okada T., Nakai M., Maeda H., Hosokawa M., Sashima T., Miyashita K. Suppressive effect of neoxanthin on the differentiation of 3T3-L1 adipose cells. Journal of Oleo Science 2008, 57:345-351.
91. Olsen S.O. Understanding the relationship between age and seafood consumption: The mediating role of attitude, health involvement and convenience. Food Quality and Preference 2003, 14:199-209.
92. Padwal R.S., Majumdar S.R. Drug treatments for obesity: Orlistat, sibutramine, and rimonabant. The Lancet 2007, 369:71-77.
93. Park M.H., Jeon Y.J., Kim H.J., Han J.S. Effect of diphlorethohydroxycarmalol isolated from Ishige okamurae on apoptosis in 3T3-L1 preadipocytes. Phytotherapy Research 2013, 27:931-936.
94. Park Y.-K., Lee T.-Y., Choi J.-S., Hong V.S., Lee J., Park J.-W., Jang B.-C. Inhibition of adipogenesis and leptin production in 3T3-L1 adipocytes by a derivative of meridianin C. Biochemical and Biophysical Research Communications 2014, 452:1078-1083.
95. Parra D., Ramel A., Bandarra N., Kiely M., Martínez J.A., Thorsdottir I. A diet rich in long chain omega-fatty acids modulates satiety in overweight and obese volunteers during weight loss. Appetite 2008, 51:676-680.
96. Parrish C., Pathy D., Angel A. Dietary fish oils limit adipose tissue hypertrophy in rats. Metabolism: Clinical and Experimental 1990, 39:217-219.
97. Pelkman C.L., Navia J.L., Miller A.E., Pohle R.J. Novel calcium-gelled, alginate-pectin beverage reduced energy intake in nondieting overweight and obese women: Interactions with dietary restraint status. The American Journal of Clinical Nutrition 2007, 86:1595-1602.
98. Peters H.P., Koppert R.J., Boers H.M., Ström A., Melnikov S.M., Haddeman E., Schuring E.A., Mela D.J., Wiseman S.A. Dose-dependent suppression of hunger by a specific alginate in a low-viscosity drink formulation. Obesity (Silver Spring) 2011, 19:1171-1176.
99. Plaza M., Cifuentes A., Ibáñez E. In the search of new functional food ingredients from algae. Trends in Food Science & Technology 2008, 19:31-39.
100. Pomin V.H. Holothurian fucosylated chondroitin sulfate. Marine Drugs 2014, 12:232-254.
101. Pomponi S.A. The bioprocess-technological potential of the sea. Journal of Biotechnology 1999, 70:5-13.
102. Racette S.B., Deusinger S.S., Deusinger R.H. Obesity: Overview of prevalence, etiology, and treatment. Physical Therapy 2003, 83:276-288.
103. Rahmouni K., Correia M.L., Haynes W.G., Mark A.L. Obesity-associated hypertension new insights into mechanisms. Hypertension 2005, 45:9-14.
104. Rinaudo M. Chitin and chitosan: Properties and applications. Progress in Polymer Science 2006, 31:603-632.
105. Rodgers R.J., Tschöp M.H., Wilding J.P. Anti-obesity drugs: Past, present and future. Disease Models & Mechanisms 2012, 5:621-626.
106. Rosenberg I.H., Beisel W.R., Gordon J.E., Katz M., Keusch G.T., Luckey T.D., Mata L.J. Infant and child enteritis-malabsorption-malnutrition: The potential of limited studies with low-dose antibiotic feeding. The American Journal of Clinical Nutrition 1974, 27:304-309.
107. Rucker D., Padwal R., Li S.K., Curioni C., Lau D.C. Long term pharmacotherapy for obesity and overweight: Updated meta-analysis. British Medical Journal 2007, 335:1194.
108. Saidpour A., Kimiagar M., Zahediasl S., Ghasemi A., Vafa M., Abadi A., Daneshpour M., Zarkesh M. The modifying effects of fish oil on fasting ghrelin mRNA expression in weaned rats. Gene 2012, 507:44-49.
109. Senthilkumar K., Kim S.-K. Marine invertebrate natural products for anti-inflammatory and chronic diseases. Evidence-based Complementary and Alternative Medicine 2013, 2013:572859.
110. Singh I.P., Bharate S.B. Phloroglucinol compounds of natural origin. Natural Product Reports 2006, 23:558-591.
111. Small C.J., Bloom S.R. Gut hormones and the control of appetite. Trends in Endocrinology & Metabolism 2004, 15:259-263.
112. Stephens J.M. The fat controller: Adipocyte development. PLoS Biology 2012, 10:e1001436.
113. Stern J., Gades M. Chitosan supplementation and fecal fat excretion in men and women. Obesity Research 2003, 11:A90.
114. Suzuki K., Simpson K.A., Minnion J.S., Shillito J.C., Bloom S.R. The role of gut hormones and the hypothalamus in appetite regulation. Endocrine Journal 2010, 57:359-372.
115. Swinburn B.A., Caterson I., Seidell J.C., James W.P. Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutrition 2004, 7:123-146.
116. Thorsdottir I., Tomasson H., Gunnarsdottir I., Gisladottir E., Kiely M., Parra M.D., Bandarra N.M., Schaafsma G., Martinez J.A. Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. International Journal of Obesity 2007, 31:1560-1566.
117. Thuny F., Richet H., Casalta J.P., Angelakis E., Habib G., Raoult D. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS ONE 2010, 5:e9074.
118. Tobias D.K., Pan A., Jackson C.L., O'Reilly E.J., Ding E.L., Willett W.C., Manson J.E., Hu F.B. Body-mass index and mortality among adults with incident type 2 diabetes. The New England Journal of Medicine 2014, 370:233-244.
119. Vázquez C., Botella-Carretero J.I., Corella D., Fiol M., Lage M., Lurbe E., Richart C., Fernández-Real J.M., Fuentes F., Ordóñez A., de Cos A.I., Salas-Salvadó J., Burguera B., Estruch R., Ros E., Pastor O., Casanueva F.F. White fish reduces cardiovascular risk factors in patients with metabolic syndrome: The WISH-CARE study, a multicenter randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases 2014, 24:328-335.
120. Vo T.-S., Kim S.-K. Potential anti-HIV agents from marine resources: An overview. Marine Drugs 2010, 8:2871-2892.
121. Vucenik I., Stains J.P. Obesity and cancer risk: Evidence, mechanisms, and recommendations. Annals of the New York Academy of Sciences 2012, 1271:37-43.
122. Wadikar D., Premavalli K. Appetite control and obesity. Critical Reviews in Food Science and Nutrition 2012, 52:949-956.
123. Wang Y., Wang J., Yanagita R.C., Liu C., Hu X., Dong P., Xue C., Xue Y. Effects of two sulfated triterpene saponins echinoside A and holothurin A on the inhibition of dietary fat absorption and obesity reduction. Bioscience, Biotechnology, and Biochemistry 2014, 78:139-146.
124. Woo M.N., Jeon S.M., Shin Y.C., Lee M.K., Kang M., Choi M.S. Anti-obese property of fucoxanthin is partly mediated by altering lipid-regulating enzymes and uncoupling proteins of visceral adipose tissue in mice. Molecular Nutrition & Food research 2009, 53:1603-1611.
125. Wynne K., Stanley S., McGowan B., Bloom S. Appetite control. Journal of Endocrinology 2005, 184:291-318.
126. Xu H., Wang J., Chang Y., Xu J., Wang Y., Long T., Xue C. Fucoidan from the sea cucumber Acaudina molpadioides exhibits anti-adipogenic activity by modulating the Wnt/β-catenin pathway and down-regulating the SREBP-1c expression. Food & Function 2014, 5:1547-1555.
127. Xu H., Wang J., Zhang X., Li Z., Wang Y., Xue C. Inhibitory effect of fucosylated chondroitin sulfate from the sea cucumber Acaudina molpadioides on adipogenesis is dependent on Wnt/β-catenin pathway. Journal of Bioscience and Bioengineering 2015, 119:85-91.
128. Yavorska N. Sodium alginate - A potential tool for weight management: Effect on subjective appetite, food intake, and glycemic and insulin regulation. Journal of Undergraduate Life Sciences 2012, 6.
129. Zabolotny J.M., Bence-Hanulec K.K., Stricker-Krongrad A., Haj F., Wang Y., Minokoshi Y., Kim Y.-B., Elmquist J.K., Tartaglia L.A., Kahn B.B. PTP1B regulates leptin signal transduction in vivo. Developmental Cell 2002, 2:489-495.
130. Zhang Z.-Y., Lee S.-Y. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity. Expert Opinion on Investigational Drugs 2003, 12:223-233.